• 1 January 1977
    • journal article
    • research article
    • Vol. 38 (1), 42-45
Abstract
In a double-blind, crossover, placebo-controlled study, consisting of 100 clinical trials, the active drug (sodium cromoglycate) wqs effective in 83.2%, while in 11.6% the placebo was judged more effective (P < 0.0001). Four patients suffered minor side effects. No deleterious effect on the nasal mucosa was noticed and no one complained that the drug produced sedation.